Similarly, in patients with inflammatory bowel disease, a retrospective cohort study found that those with normal vitamin D levels at the initiation of anti-TNF-α therapy had a 2.64 times increased odds of achieving remission after three months compared to patients with low vitamin D levels, suggesting that adequate vitamin D may enhance the effectiveness of anti-TNF-α treatments [20]. The gene discussed is TNF; the disease is inflammatory bowel disease.